STUDY OF CLINICAL/HORMONAL EFFECTS OF GHRP-2 AND GHRH-2+GHRH IN THE ELDERLY

GHRP-2 和 GHRH-2 GHRH 对老年人的临床/激素影响的研究

• 批准号: 6122072
• 负责人: CYRIL Y BOWERS
• 金额: $ 1.12万
• 依托单位: TULANE UNIVERSITY OF LOUISIANA
• 依托单位国家: 美国
• 财政年份: 1999
• 资助国家: 美国
• 起止时间: 1999-07-19 至 1999-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6122072
• 关键词: clinical research; clinical trial phase I; dosage; drug screening /evaluation; endocrine pharmacology; growth hormone releasing hormone; hormone therapy; human old age (65+); human subject; secretion; somatotropin; synthetic peptide; vital statistics

This clinical trial is to investigate the clinical and hormonal effects of growth hormone releasing peptide (GHRP-2) and Growth Hormone Releasing Peptide + Growth Hormone Releasing Hormone (GHRH) in the elderly. This study is to determine the safety of growth hormone, clinical effects on vital signs, if these hormones will stimulate growth hormone secretion and the dose response relationship and time course.

本临床试验旨在探讨生长激素释放肽(GHRP-2)和生长激素释放肽+生长激素释放激素(GHRH)对老年人的临床和激素作用。本研究旨在确定生长激素的安全性、临床对生命体征的影响、这些激素是否会刺激生长激素的分泌以及剂量反应关系和时间进程。